Maynard Um
-
-
-
-
-
-
-
Perspective Therapeutics, Inc. (CATX) Tops Q1 EPS by 5c
-
-
-
-
-
-
-
Piper Sandler Starts Perspective Therapeutics Inc (CATX) at Overweight
-
-
-
-
-
-
-
H.C. Wainwright Reiterates Buy Rating on Perspective Therapeutics Inc (CATX)
-
-
-
-
-
-
-
Cantor Fitzgerald Reports Key Takeaways from Call With RadioMedia CEO
-
-
-
-
-
-
-
Perspective Therapeutics (CATX) Announces First Patient Dosed with VMT01 in Combination with Nivolumab in a Phase 1/2a Study of MC1R-Positive Metastatic Melanoma
-
-
-
-
-
-
-
Oppenheimer Reiterates Outperform Rating on Perspective Therapeutics Inc (CATX)
-
-
-
-
-
-
-
Perspective Therapeutics, Inc. (CATX) Misses Q2 EPS by 16c
-
448,114 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

